FindTrial
Sign In

Link Between blood Prolactin Levels and the Severity of Chronic Liver Disease

Correlation between serum prolactin levels and severity of chronic liver disease - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/02/081168
Enrollment
100
Registered
2025-02-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K746- Other and unspecified cirrhosis ofliver

Interventions

Intervention1: nil: nil Control Intervention1: nil: nil

Sponsors

Dr Priyank Patel
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Male Patients above the age of 18 years with diagnosis of chronic liver disease and/or its complications, who consent to participate in this study

Exclusion criteria

Exclusion criteria: Patients on medications known to elevate prolactin level such as neuroleptics, metoclopramide, methyldopa, reserpine, cyproterone acetate, morphine, cimetidine, metiamide History of chest wall trauma, Cranial surgery/ irradiation Pituitary or hypothalamic disease and seizure disorder. Patients in septic shock or severe sepsis. Chronic renal failure All female patients Patients who do not give consent

Design outcomes

Primary

MeasureTime frame
To assess the relationship between serum prolactin levels and disease severity using Child Pugh scoreTimepoint: 1 year—

Secondary

MeasureTime frame
. To assess that serum prolactin levels as predictor of complications in chronic liver disease patientsTimepoint: 1 year—

Countries

India

Contacts

Public ContactDr Tahir

Varun Arjun Medical College and Rohilkhand Hospital

dhanakar@gmail.com9843376861

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026